P386 A target 6-thioguanine nucleotide ≥125 is associated with a higher rate and longer durability of response in infliximab–thiopurine combination therapy: a retrospective study in Crohn's disease patients

Authors :: Mark G. Ward
Raphael P. Luber
Miles P. Sparrow
Viraj C. Kariyawasam
S. Munari
L. Dawson
Peter R. Gibson
Source :: Journal of Crohn's and Colitis. 11:S273-S274
Publication Year :: 2017
Publisher :: Oxford University Press (OUP), 2017.

Subjects :: medicine.medical_specialty
Crohn's disease
Thiopurine methyltransferase
biology
Combination therapy
business.industry
Gastroenterology
6-thioguanine nucleotide
Retrospective cohort study
General Medicine
medicine.disease
Infliximab
Surgery
Internal medicine
medicine
biology.protein
business
medicine.drug

Full Text Access

Tools